0
0
44 words
0
Comments
Women with osteoporosis receiving abaloparatide for 18 months followed by alendronate for 2 years had greater improvements in trabecular bone score than those receiving placebo, according to study findings. “Abaloparatide (Tymlos, Radius Health) improv…
You are the first to view
https://www.healio.com/news/endocrinology/20230113/abaloparatide-improves-bone-strength-among-women-with-osteoporosis
Create an account or login to join the discussion